5/7
08:01 am
rckt
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $53.00 price target on the stock.
Low
Report
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $53.00 price target on the stock.
5/7
07:16 am
rckt
Rating for RCKT
Low
Report
Rating for RCKT
5/7
07:16 am
rckt
Rating for RCKT
Low
Report
Rating for RCKT
4/10
08:06 am
rckt
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $53.00 price target on the stock.
Low
Report
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $53.00 price target on the stock.
4/10
06:06 am
rckt
Rating for RCKT
Low
Report
Rating for RCKT
4/10
06:06 am
rckt
Rating for RCKT
Low
Report
Rating for RCKT
4/2
07:06 am
rckt
Rating for RCKT
Medium
Report
Rating for RCKT
4/2
07:06 am
rckt
Rating for RCKT
Medium
Report
Rating for RCKT
4/2
07:06 am
rckt
Rating for RCKT
Medium
Report
Rating for RCKT
3/1
11:52 am
rckt
Rating for RCKT
Low
Report
Rating for RCKT
2/27
01:22 pm
rckt
Rating for RCKT
Low
Report
Rating for RCKT
2/27
10:17 am
rckt
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $65.00 price target on the stock.
Medium
Report
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $65.00 price target on the stock.
2/27
09:30 am
rckt
Rating for RCKT
Low
Report
Rating for RCKT